On-Demand Webinars

1. Optimizing Pediatric Product Development For Commercialization Success 4/10/2024

   Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Explore various dosing solutions and learn how to streamline your pediatric development journey.

2. Particle Size Control Through Micronization: Challenges And Solutions

   What technical issues need to be addressed if an API is to be successfully micronized? Explore a robust process development strategy that ensures all attributes critical for quality are maintained.

3. A Data-Driven Approach To Container Closure Integrity

   Gain confidence in your container closure system selection by utilizing a stepwise and data-driven approach to predicting and verifying container closure integrity.

4. Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions 9/10/2024

   Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.

5. Formulation Technologies For Developing Dry Powders For Inhalation

   Examine challenges and key considerations for spray-dried formulations for inhalation, along with a review of current technologies and approved products utilizing particle engineering approaches.

6. Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology 5/1/2024

   Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

7. How To Deal With The Complexity Of Drugs In Clinical Development

   Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.

8. Dramatic Reduction Of Solvent Usage In Pharmaceutical Spray Drying

   Using volatile processing aids to increase drug solubility in more environmentally friendly solvents, like methanol, reduces the amount of solvent required to manufacture amorphous solid dispersions (ASDs).

9. Rapid Developability Assessment Of Early Phase Molecules

   A case study illustrating how to use PBPK modeling, the developability classification system, and the biopharmaceutics drug distribution classification system to facilitate development of a molecule.

10. Managing Container Closure Related Complexities With Lyophilized Drug Products

    Using a comprehensive approach to component selection mitigates risks to fill-finish and lyo processing. Explore key considerations for selecting lyophilization stoppers suitable for intended use.